𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: Which policy?

✍ Scribed by Marco Guzzo; Pasquale Quattrone; Ettore Seregni; Roberto Bianchi; Franco Mattavelli

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
114 KB
Volume
29
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Thyroid carcinoma occurring as a second primary associated with head and neck squamous cell carcinoma (HNSCC) is unusual. The clinical management of thyroid cancer in such cases has been debated.

Methods

Between 1975 and 2004, we collected 33 cases. The associated thyroid carcinoma was diagnosed either during or as a consequence of surgery planned as head and neck cancer treatment.

Results

The associated thyroid carcinoma was never seen to recur. Five‐year overall survival was 41%. Disease‐free survival after 40 and 66 months was 11.1% and 5.6%, respectively.

Conclusions

We consider the treatment of thyroid cancer to be complete when the thyroid gland, either with or without lymph nodes, has been included in the specimen obtained during surgery for HNSCC. In the group of cases in which associated thyroid carcinoma was only found within the neck lymph nodes and the thyroid gland has not been treated, we discourage further surgical treatment or radioactive iodine therapy. Β© 2006 Wiley Periodicals, Inc. Head Neck, 2006

πŸ“œ SIMILAR VOLUMES

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Bone metastases from squamous cell carci
Bone metastases from squamous cell carcinoma of the head and neck
✍ Marc P. Pietropaoli; Timothy A. Damron; Andrei I. Vermont πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 265 KB πŸ‘ 2 views

Background and Objectives: Carcinoma of the head and neck is an uncommon primary source of bone metastases. The increasing duration of survival of these patients, however, increases the probability of late bone involvement. The objective was to identify the frequency, clinical presentation, and clin

Targeted therapies in squamous cell carc
Targeted therapies in squamous cell carcinoma of the head and neck
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Radiotherapy for basaloid squamous cell
Radiotherapy for basaloid squamous cell carcinoma of the head and neck
✍ Dr. James M. Larner; Dr. Ronald H. Malcolm; Dr. Stacey E. Mills; Dr. Henry F. Fr πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 451 KB πŸ‘ 2 views

Basaloid squamous cell carcinoma (BSCC) of the head and neck is a recently described high-grade variant of squamous cell carcinoma. It is a biologically virulent neoplasm with a propensity for nodal, as well as systemic, metastases. Because of the limited number of published reports, we reviewed dat

Immunoglobulin allotypes in patients wit
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant